Colombia Wound Care Biologics Market - Restraint
Increasing adoption of alternative wound care products and high cost of the wound care biologics products are expected to hinder growth of the Colombia wound care biologics market over the forecast period. The wound care biologic products are relatively expensive, significantly contributing towards cost of total wound management procedure, thereby deterring the patients from seeking advanced wound care. This is a major factor responsible for increasing inclination of patients towards conventional wound care management techniques such as traditional and antimicrobial dressing.
For instance, Collagenase SANTYL Ointment is the only enzymatic debride costing for around US$ 244 for 30 gm quantity. Furthermore, skin substitute products and engineered growth factor could find it difficult to make headway into the Colombian market as these are specialized products with cost that may be difficult to afford.
Traditional wound care products such as polymer dressings, cotton balls, and emulsion are still a common approach for wound healing, owing to its easy application, high accessibility to surgical hospitals, and low costs. Moreover, the medical professionals majorly prefer advanced therapies for wound management such as negative pressure wound therapy and hyperbaric therapy to minimize the occurrence of allergic reactions caused due to skin substitutes tissues. Alternative therapies such as negative pressure wound therapies and others are also proved to have higher efficacy in treating chronic wounds with well-established positive clinical results.
Colombia Wound Care Biologics Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients